End-of-day quote
Other stock markets
|
||
- EUR | - |
Sales 2024 * | 266M 289M | Sales 2025 * | 304M 329M | Capitalization | 553M 599M |
---|---|---|---|---|---|
Net income 2024 * | -10M -10.84M | Net income 2025 * | 4M 4.34M | EV / Sales 2024 * | 1.74 x |
Net cash position 2024 * | 87.65M 95.06M | Net cash position 2025 * | 109M 118M | EV / Sales 2025 * | 1.46 x |
P/E ratio 2024 * |
-51.3
x | P/E ratio 2025 * |
-205
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.66% |
Latest transcript on PHARMING GROUP
Managers | Title | Age | Since |
---|---|---|---|
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Jeroen Wakkerman
DFI | Director of Finance/CFO | 55 | 20-11-15 |
Anurag Relan
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Pykett
BRD | Director/Board Member | 60 | 20-12-10 |
Leonard Kruimer
BRD | Director/Board Member | 66 | 21-05-18 |
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
1st Jan change | Capi. | |
---|---|---|
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |